The Safety and Efficacy of Tolvaptan for Patients With Tricuspid Regurgitation and Right Heart Failure After Left Heart Valves Replacement
Clinical trial NCT02644616 · COMPLETED
Trial details
- NCT number
- NCT02644616
- Sponsor
- Shanghai Chest Hospital
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-01
- Primary completion
- 2016-12-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.